Temporary Suspension Notice The Commission on Human Medicines (CHM) has temporarily restricted the use of IXCHIQ Chikungunya vaccine in people aged 65 years and over following very rare but serious adverse events reported globally. This is a precautionary measure to allow further investigation. Key Points IXCHIQ should not be administered to patients aged 65 years […]
MHRA Alert – IXCHIQ Chikungunya vaccine: age restrictions updated following safety review
IXCHIQ Chikungunya vaccine: updated use restrictions The MHRA has completed a safety review of IXCHIQ (chikungunya vaccine) and, following recommendations from the Commission on Human Medicines (CHM), important changes to its licensed indications have been made. Key points IXCHIQ is no longer indicated for adults over 60 years of age The vaccine is now contraindicated […]